Esperela, Lilia F.

HRN: 22-55-89  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/02/2023
02/08/2023
IV
4.5gm
Q6
Amoebic Liver Abscess
Waiting Final Action 
02/02/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/02/2023
02/08/2023
IV
500mg
Q8
Amoebic Liver Abscess
Waiting Final Action 
02/02/2023
CEFTRIAXONE 1G (VIAL)
02/02/2023
02/08/2023
IV
2gm
Q24
Typhoid Fever
Waiting Final Action 
02/11/2023
CEFIXIME 200MG (CAP)
02/11/2023
02/17/2023
PO
200mg
BID
Typhoid Fever
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: